Cardiovascular disease in children with CKD or ESRD

Nature Reviews Nephrology

Volumn 5, Issue 4, 2009, Pages 229-235

  Lilien, Marc R ^a   Groothoff, Jaap W ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; SEVELAMER;

AGE DISTRIBUTION; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY INTIMA; ARTERY MEDIA; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL CALCIFICATION; BLOOD VOLUME; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHRONIC KIDNEY DISEASE; DIALYSIS; ENDOTHELIAL DYSFUNCTION; HEART DEATH; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; KIDNEY FAILURE; MORBIDITY; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RENAL REPLACEMENT THERAPY; REVIEW; SYSTOLIC BLOOD PRESSURE; AGE; CHRONIC KIDNEY FAILURE; PATHOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

AGE FACTORS; CARDIOVASCULAR DISEASES; CHILD; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 67049160140     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.10     Document Type: Review

References (60)

1. McDonald, S. P. & Craig, J. C. Long-term survival of children with end-stage renal disease. N. Engl. J. Med. 350, 2654-2662 (2004).
2. Groothoff, J. W. et al. Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int. 61, 621-629 (2002).
3. Chavers, B. M., Li, S. , Collins, A. J. & Herzog, C. A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 62, 648-653 (2002).
4. Parekh, R. S. , Carroll, C. E., wolfe, R. A. & Port, F. K. Cardiovascular mortality in children and young adults with end-stage kidney disease. J. Pediatr. 141, 191-197 (2002).
5. Kavey, R. E. et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert Panel on Population and Prevention science; the Councils on Cardiovascular Disease in the Young, epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the interdisciplinary working Group on Quality of Care and Outcomes research: endorsed by the American Academy of Pediatrics. Circulation 114, 2710-2738 (2006).
6. Mitsnefes, M. M. Cardiovascular disease in children with chronic kidney disease. Adv. Chronic Kidney DiS. 12, 397-405 (2005).
7. Oh, J. et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106, 100-105 (2002).
8. Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney DiS. 32 (Suppl. 3), s112-s119 (2002).
9. Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
10. London, G. M. et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int. 65, 700-704 (2004).
11. Zoccali, C. The endothelium as a target in renal diseaseS. J. Nephrol. 20 (Suppl. 12), s39-s44 (2002).
12. Johnson, R. C., Leopold, J. A. & Loscalzo, J. vascular calcification: pathobiological mechanisms and clinical implicationS. Circ. ReS. 99, 1044-1059 (2006).
13. Choi, J. H. et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler. Thromb. Vasc. Biol. 24, 1246-1252 (2004).
14. Werner, N. et al. Circulating endothelial progenitor cells and cardiovascular outcomeS. N. Engl. J. Med. 353, 999-1007 (2005). (Pubitemid 41262334)
15. Jie, K. E., Goossens, M. H., Van Oostrom, O., Lilien, M. R. & Verhaar, M. C. Circulating endothelial progenitor cell levels are higher during childhood than in adult life. Atherosclerosis 202, 345-347 (2009).
16. Civilibal, M. et al. Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr. Nephrol. 22, 1021-1029 (2007).
17. Lilien, M. R. et al. vascular function in children after renal transplantation. Am. J. Kidney DiS. 41, 684-691 (2003).
18. Kari, J. A. et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 52, 468-472 (1997).
19. Lilien, M. R., Koomans, H. A. & schroder, C. H. Hemodialysis acutely impairs endothelial function in children. Pediatr. Nephrol. 20, 200-204 (2007).
20. Wang, S. et al. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clin. Chem. Lab. Med. 45, 1305-1312 (2007).
21. Hussein, G., Bughdady, Y., Kandil, M. E., Bazaraa, H. M. & Taher, H. Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr. Nephrol. 23, 2025-2030 (2008).
22. Wilson, A. C. et al. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr. Nephrol. 23, 1297-1302 (2007).
23. Lilien, M. R., schroder, C. H., Levtchenko, E. N. & Koomans, H. A. Growth hormone therapy influences endothelial function in children with renal failure. Pediatr. Nephrol. 19, 785-789 (2004).
24. London, G. M. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731-1740 (2003).
25. Blacher, J. et al. impact of aortic stiffness on survival in end-stage renal disease. Circulation 99, 2434-2439 (1999).
26. Tonelli, M., sacks, F., Pfeffer, M., Gao, Z. & Curhan, G. relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627-2633 (2005).
27. Giachelli, C. M. et al. vascular calcification and inorganic phosphate. Am. J. Kidney DiS. 38 (Suppl. 1), s34-s37 (2001).
28. Jono, S. et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. ReS. 87, e10-e17 (2000).
29. London, G. M., Marchais, S. J., Guérin, A. P. & Métivier, F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr. Opin. Nephrol. HypertenS. 14, 525-531 (2005).
30. Jourdan, C. et al. Normative values for intima- media thickness and distensibility of large arteries in healthy adolescentS. J. HypertenS. 23, 1707-1715 (2007).
31. Lorenz, M. W., Markus, H. S. , Bots, M. L., Rosvall, M. & Sitzer, M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and metaanalysiS. Circulation 115, 459-467 (2007).
32. Covic, A. et al. increased arterial stiffness in children on haemodialysiS. Nephrol. Dial. Transplant. 21, 729-735 (2006).
33. Shroff, R. C. et al. Mineral metabolism and vascular damage in children on dialysiS. J. Am. Soc. Nephrol. 18, 2996-3003 (2007).
34. Groothoff, J. W. et al. increased arterial stiffness in young adults with end-stage renal disease since childhood. J. Am. Soc. Nephrol. 13, 2953-2961 (2002).
35. Litwin, M. et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J. Am. Soc. Nephrol. 16, 1494-1500 (2005).
36. Mitsnefes, M. M. et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J. Am. Soc. Nephrol. 16, 2796-2803 (2005).
37. Litwin, M. et al. evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol. Dial. Transplant. 23, 2552-2557 (2008).
38. Goodman, W. G. et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysiS. N. Engl. J. Med. 342, 1478-1483 (2000).
39. Civilibal, M. et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr. Nephrol. 21, 1426-1433 (2006).
40. Amann, K., Breitbach, M., Ritz, E. & Mall, G. Myocyte/capillary mismatch in the heart of uremic patients. J. Am. Soc. Nephrol. 9, 1018-1022 (1998).
41. Mall, G., Huther, w, schneider, J., Lundin, P. & ritz, E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol. Dial. Transplant. 5, 39-44 (1990).
42. Bosch, A., Ulmer, H. E., Keller, H. E., Bonzel, K. E. & scharer, K. electrocardiographic monitoring in children with chronic renal failure. Pediatr. Nephrol. 4, 140-144 (1990). (Pubitemid 20114133)
43. Kocak, G. et al. QT/corrected QT (QTc) intervals and QT/QTc dispersions in children with chronic renal failure. Int. J. Cardiol. 70, 63-67 (1999).
44. Bakiler, A. R., Yavascan, O., Harputluoglu, N., Kara, O. D. & Aksu, N. evaluation of aortic stiffness in children with chronic renal failure. Pediatr. Nephrol. 22, 1911-1919 (2007).
45. Ulinski, T., Genty, J., viau, C., Tillous-Borde, i. & Deschenes, G. reduction of left ventricular hypertrophy in children undergoing hemodialysiS. Pediatr. Nephrol. 21, 1171-1178 (2006).
46. Mitsnefes, M. M. et al. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr. Transplant. 5, 279-284 (2001).
47. Mitsnefes, M. M. et al. impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 65, 1461-1466 (2004).
48. Mitsnefes, M. M. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J. Pediatr. 149, 671-675 (2006).
49. Becker-Cohen, R. et al. improved left ventricular mass index in children after renal transplantation. Pediatr. Nephrol. 23, 1545-1550 (2008).
50. Gruppen, M. P. et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int. 63, 1058-1065 (2003).
51. Matteucci, M. C. et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J. Am. Soc. Nephrol. 17, 218-226 (2006).
52. Matteucci, M. C. et al. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int. 56, 1566-1570 (1999).
53. Flynn, J. T. et al. Blood pressure in children with chronic kidney disease: A report from the Chronic Kidney Disease in Children study. Hypertension 52, 631-637 (2008).
54. Bennett-richards, K. J. et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 62, 1372-1378 (2002).
55. Bennett-richards, K. et al. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105, 1810-1815 (2002).
56. Briese, S. , Claus, M. & Querfeld, U. Arterial stiffness in children after renal transplantation. Pediatr. Nephrol. 23, 2241-2245 (2008).
57. Bilginer, Y. et al. Carotid intima-media thickness in children and young adults with renal transplant: internal carotid artery vS. common carotid artery. Pediatr. Transplant. 11, 888-894 (2007).
58. Walsh, M., Culleton, B., Tonelli, M. & Manns, B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 67, 1500-1508 (2005).
59. Fischbach, M. et al. Daily on-line haemodiafiltration: A pilot trial in children. Nephrol. Dial. Transplant. 19, 2360-2367 (2004).
60. Muller, D. et al. intensified hemodialysis regimens: neglected treatment options for children and adolescentS. Pediatr. Nephrol. 23, 1729-1736 (2008).